(FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -105.64%-1.4M | -430.41%-266.98K | -104.08%-347.75K | -8.30%-202.29K | -113.29%-585.42K | 36.96%-681.98K | -3,203.21%-50.33K | 53.30%-170.4K | 59.12%-186.78K | -4.87%-274.48K |
Net income from continuing operations | -415.99%-5.47M | -2,033.65%-3.6M | -112.93%-1.04M | -205.36%-453K | -47.85%-378.36K | 88.36%-1.06M | 97.89%-168.74K | -34.90%-486.68K | 60.26%-148.35K | 33.63%-255.92K |
Operating gains losses | -75.40%-183.92K | ---164.19K | ---- | ---- | ---- | -888.49%-104.86K | ---- | ---- | ---- | ---- |
Depreciation and amortization | 12.17%15.28K | 46.03%5.06K | -6.70%3.11K | -1.67%3.41K | 10.20%3.71K | -8.07%13.62K | 2.36%3.47K | -16.25%3.33K | 86.68%3.46K | -39.96%3.36K |
Asset impairment expenditure | -135.87%-63.31K | ---- | ---- | ---- | ---- | -97.70%176.52K | --0 | ---- | ---- | ---- |
Remuneration paid in stock | 1,262.57%4.12M | 3,250.79%3.24M | 368.12%658.87K | 369.30%114.73K | 176.77%112.95K | -25.69%302.59K | 134.79%96.59K | 35.43%140.75K | -80.72%24.45K | -69.84%40.81K |
Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---60.01K | ---- | ---- | ---- | ---- |
Change In working capital | 249.88%174.37K | 74.22%319.2K | 715.90%26.57K | 329.60%152.31K | -416.04%-323.71K | 152.82%49.84K | -23.68%183.22K | 95.90%-4.31K | 68.75%-66.34K | -267.59%-62.73K |
-Change in receivables | -161.16%-10.14K | -100.31%-452 | 91.60%-12.88K | -61.63%11.79K | -46.98%-8.6K | -21.46%16.58K | 251.24%145.04K | -1,839.11%-153.35K | 909.29%30.74K | 30.93%-5.85K |
-Change in prepaid assets | 93.33%-1.4K | -473.30%-22.49K | -16.54%1.02K | 692.72%122.78K | -4,219.78%-102.71K | -677.32%-20.92K | -108.83%-3.92K | -81.67%1.22K | 58.13%-20.71K | 24.65%2.49K |
-Change in payables and accrued expense | 243.15%185.91K | 712.75%342.13K | -50.61%38.43K | 378.96%17.74K | -257.76%-212.4K | 145.49%54.18K | -72.72%42.1K | 182.05%77.81K | 96.21%-6.36K | -460.60%-59.37K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -105.64%-1.4M | -430.41%-266.98K | -104.08%-347.75K | -8.30%-202.29K | -113.29%-585.42K | 36.96%-681.98K | -3,203.21%-50.33K | 53.30%-170.4K | 59.12%-186.78K | -4.87%-274.48K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -746.88%-1.11M | -4,514.54%-763.41K | -65.29%-183.9K | -991.86%-136.54K | 2.88%-23.6K | 64.94%-130.77K | 116.41%17.29K | 44.69%-111.26K | 62.42%-12.51K | 26.89%-24.3K |
Capital expenditure reported | -322.03%-1.01M | -645.10%-675.62K | -54.41%-171.79K | -991.86%-136.54K | 2.88%-23.6K | 37.48%-238.73K | 15.53%-90.68K | 46.51%-111.26K | 62.42%-12.51K | 26.89%-24.3K |
Net PPE purchase and sale | -192.53%-99.9K | ---87.79K | ---- | ---- | ---- | 1,118.74%107.97K | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -746.88%-1.11M | -4,514.54%-763.41K | -65.29%-183.9K | -991.86%-136.54K | 2.88%-23.6K | 64.94%-130.77K | 116.41%17.29K | 44.69%-111.26K | 62.42%-12.51K | 26.89%-24.3K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 714.58%6.68M | 634.18%110.74K | 2,369.46%5.63M | -194.51%-148.27K | 158.14%1.08M | -34.79%820.06K | 170.22%15.08K | -52.47%228.13K | -40.35%156.88K | -21.64%419.98K |
Net issuance payments of debt | -48,211.03%-442.53K | --0 | 95.19%-1.05K | -4,240.77%-243.27K | ---198.21K | -100.48%-916 | 121.10%15.08K | ---21.88K | --5.88K | --0 |
Net common stock issuance | 662.18%6.26M | ---754.5K | 2,153.80%5.63M | 17.28%95K | 161.71%1.28M | -19.19%820.98K | --0 | -47.92%250K | --81K | -8.58%489.98K |
Proceeds from stock option exercised by employees | --865.25K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---70K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 714.58%6.68M | 634.18%110.74K | 2,369.46%5.63M | -194.51%-148.27K | 158.14%1.08M | -34.79%820.06K | 170.22%15.08K | -52.47%228.13K | -40.35%156.88K | -21.64%419.98K |
Net cash flow | ||||||||||
Beginning cash position | 124.18%36.41K | 12,089.07%5.1M | -73.96%23.69K | 268.72%511.08K | 124.18%36.41K | -89.41%16.24K | -57.34%41.84K | -44.44%90.99K | -62.90%138.61K | -89.41%16.24K |
Current changes in cash | 56,916.26%4.17M | -5,021.37%-919.64K | 9,630.92%5.1M | -1,048.61%-487.09K | 291.97%475.1K | 103.71%7.31K | 85.66%-17.96K | 37.75%-53.53K | 81.33%-42.41K | -49.71%121.21K |
Effect of exchange rate changes | -98.05%251 | 111.15%26.44K | -680.91%-25.47K | 94.33%-296 | -136.77%-428 | -78.65%12.85K | -71.13%12.52K | -78.40%4.38K | -130.07%-5.22K | 105.59%1.16K |
End cash Position | 11,454.99%4.21M | 11,454.99%4.21M | 12,089.07%5.1M | -73.96%23.69K | 268.72%511.08K | 124.18%36.41K | 124.18%36.41K | -57.34%41.84K | -44.44%90.99K | -62.90%138.61K |
Free cash from | -172.60%-2.51M | -630.72%-1.03M | -88.76%-531.65K | -70.02%-338.82K | -103.84%-609.02K | 37.10%-920.72K | -33.37%-141.01K | 50.83%-281.65K | 59.34%-199.28K | -1.29%-298.77K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data